Trial Profile
A retrospective trial to evaluate efficacy of Ledipasvir/Sofosbuvir in non-cirrhotic treatment-naïve, hepatitis C genotype 1 patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 18 May 2016 New trial record
- 17 Apr 2016 Results (n=192) presented at The International Liver Congress™ 2016.